The International Trade Commission will accept input from interested parties through April 13 as part of a new factfinding investigation on the impact on the U.S. economy, U.S. industry, and product sourcing over a six-year period of revoking permanent normal trade relations (PNTR) treatment for all products of China. Due to the accelerated timeline of this investigation, the ITC does not plan to hold a public hearing in connection with the preparation of this report.
The ITC intends to cover the following topics, to the extent practicable:
- the results of the agency’s investigation and analysis, including detailed information, to the extent practicable, on U.S. trade, production, and prices in the industries that could be directly and most affected by the imposition of rates of duty in column 2 of the HTSUS on products of China; and
- an examination of an alternative scenario where Congress revokes PNTR treatment with a five-year phase-in of tariffs on a subset of national security products.
Revoking PNTR treatment with respect to Chinese goods would result in a substantial increase in U.S. import duties for those products, as column 2 duty rates are typically markedly higher than regular (column 1) rates.
The ITC has launched a separate probe into Chinese state support and pricing practices in the biotechnology sector and will assess how these practices may be affecting the market share and competitiveness of the U.S. industry. To the extent practicable, this report will:
- review the extent to which Chinese state support and pricing practices in the biotech sector, including genomic sequencing, synthetic biology, and active pharmaceutical ingredient manufacturing, may be affecting U.S. market share and competitiveness; and
- outline the ITC’s findings and identify impacts to U.S. biotech producers and service providers.
The ITC will hold a hearing in connection with this investigation May 27-28. Requests to appear at the hearing are due by May 11, prehearing briefs and statements must be submitted by May 14, electronic copies of hearing oral arguments are due by May 20, posthearing briefs are due by June 11, and all other written submissions must be filed by July 17.
Copyright © 2026 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.